ResearcherChina Pharmaceutical UniversityActive in the last 2 years
Peng Yang
Matched on ORCID iD 0000-0002-2613-941X; OpenAlex author ID A5044009408. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD-Mediated EMT Signaling Pathway. Last author DOI 10.1002/advs.202506718↗
- PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis. Last author DOI 10.3389/fimmu.2022.805311↗
- Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma. Last author DOI 10.3390/cancers14153629↗
- Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. Co-author DOI 10.1007/s11427-019-1753-3↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jiayu Ding · 3 shared papers, 2022–2025 · strength 0.51
- Paper ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PA… DOI 10.1002/advs.202506718↗
- Paper PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and … DOI 10.3389/fimmu.2022.805311↗
- Paper Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma. DOI 10.3390/cancers14153629↗
- Wenbin Kuang · 3 shared papers, 2022–2025 · strength 0.51
- Paper ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PA… DOI 10.1002/advs.202506718↗
- Paper PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and … DOI 10.3389/fimmu.2022.805311↗
- Paper Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma. DOI 10.3390/cancers14153629↗
- Xiao Wang · 3 shared papers, 2022–2025 · strength 0.51
- Paper ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PA… DOI 10.1002/advs.202506718↗
- Paper PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and … DOI 10.3389/fimmu.2022.805311↗
- Paper Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma. DOI 10.3390/cancers14153629↗
- Pyone Myat Thu · 1 shared paper, 2021 · strength 0.14
- Ji Li · 1 shared paper, 2021 · strength 0.14
- Ping Li · 1 shared paper, 2021 · strength 0.14
- Xiaoxiao Liu · 1 shared paper, 2021 · strength 0.14
- Xiaojun Xu · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.